COAGULATION ACTIVITY AND D-DIMER IN SEPSIS PATIENTS

Anggraini D, Maani H, Rofinda Z D

Abstract


Sepsis is a systemic inflammatory response with the presence of suspected or proven infection. The inflammation will increase the production of proinflammatory cytokines that will activate coagulation and suppress fibrinolytic system. An imbalance of hemostasis mechanism and inflammation in sepsis can progress into Disseminated Intravascular Coagulation (DIC). The objective of this study was to determine the coagulation activity (platelet count, Prothrombin Time (PT), activated Partial Thromboplastin Time (aPTT)), and D-dimer in sepsis patients. A descriptive study was conducted at the Dr. M. Djamil Hospital on December 2012-July 2013. Subjects were adult patients with two or more of four criteria for Systemic Inflammatory Response Syndrome (SIRS) and presence of suspected or proven infection admitted to the Department of Internal Medicine. Laboratory examination was conducted in the Clinical Pathology Laboratory Dr. M. Djamil Hospital including the coagulation activity and D-dimer level. Data were processed manually and presented in distribution tables, and diagrams. Subjects of this study were 54 sepsis patients, consisting of 57% males and 43% females with a median age of 53.5 year-old, platelet count 188.5 x 103/µL, PT 13.7 seconds, aPTT 39.3 seconds, and D-dimer level 1.15 μg/mL. Based on this research it can be concluded that coagulation activity in sepsis patients showed that platelets count were still in the normal range while PT and aPTT were prolonged and D-dimer levels were increased.

 


Keywords


Coagulation activity, D-dimer, sepsis

Full Text:

PDF

References


American College of Chest Physicians. Definition for sepsis and organ failure and guidelines for the use of innovation therapies in sepsis. In: Crit care med. 1992; 864-74.

Hague KN. Definition of bloodstream infection in newborn. In: Pediatr crit care met. 2005; 6(3): 45-9.

Angus DC, Linde-Zwirble WT, Lidicker J. Epidemiology of severe sepsis in United States. In: Crit care med, 2001; 29(7): 1303-10.

Siegal T, Seligsohn U, Aghai E. Clinical and laboratory aspects of disseminated intravascular coagulation (DIC): A study of 118 cases. In: J Thromb Haemost. 1978; 39(1): 122.

Engel C, Brunkhorst F, Bone HG, Brunkhorst R, Gerlach H, Grond S. Epidemiology of sepsis in Germany: Results froa national prospective multicenter study. In: Intensive care med. 2007; 33(4): 606-18.

Chu AJ. Tissue factors, blood coagulation, and beyond. In: Intrn J Inflams. 2011; 2011: 1-30.

Root RK, Jacobs R. Septicemia and septic shock. In: Wilson JD, Braunwald E, Isselbacker KJ, et al. Eds. Harison’s Principles of Internal Medicine. 12th Ed., New York, McGraw- Hill, 1991; 502-7.

Hoffman R. Hematology: Basic principles and practice. 3rd Ed., Philadelphia, Churcill Livingstone Inc. 2000; 1000-33.

Zeerleder S, Hack E, Wuielemin W. Disseminated intravascular coagulation in sepsis. In: Chest Journal. 2005; 128(4): 2864-75.

Dempfle CE. Coagulopathy of sepsis. In: Thromb Haemost journal. 2004; 91: 213-24.

Fatma. Respons imunitas yang rendah pada manusia usia lanjut. In: MKM FKUI, 2006; 01(10): 46-53.

Kresno SB. Respons imun pada inflamasi. Dalam: Imunologi Diagnosis dan prosedur Ed 5., Jakarta, Badan Penerbit Fakultas Kedokteran Universitas Indonesia, 2010; 213-25.

Park R, Song J, Soo S. Elevated level of activated and inactivated thrombin activable fibrinolysis inhibitor in patien sepsis. In: Korean Journal of Hematology 2010; 45(4): 264-68.

Lorente L, Martin M, Gonzalez PA, Rodriquez AD, Labarta L, Diaz C et al. Prognostic value of malondialdehyde serum levels in severe sepsis. 2013; 8(1): 1-5.

Munford RS. Severe sepsis and septic shock. In: Harrison’s Principles of internal medicine. 16th Ed., 2005; 1606-11.

Reinhart K, Meisner M, Brunkhorst FM. Markers for sepsis diagnostics. In: Crit Care Clin. 2006; 22(3); 503-19.

Kinazewits GT, Yan SB, Basson B, Comp P, Russel JA, Cariou A, et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism. In: Crit Care 2004; 8(2): 82-90.

Estrin MA, Wehausen CE, Jessen CR, Lee JA. Sepsis-Disseminated intravascular coagulation in cats. In: J Vet Intern Med. 2006; 20(6): 1334-9.

Mavrommatis AC, Theodoritis T, Economou M, Eli E, Kokkinou C, et al. Activation of the fibrinolytic system and utilization of coagulation inhibitor in sepsis. In: Journal of Intensive Care Med. 2001; 27(12): 1853-8.




DOI: http://dx.doi.org/10.24293/ijcpml.v24i2.1315

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.